Conclusions
PTSD-related, depression, PTSD, anxiety
The costs of untreated or incompletely treated PTSD to women veterans and their families, the VA, and society are sizable. The VA is facing exponential increases in the number of women enrolled and with PTSD. Given the limitations of first-line EBTs in the VA, new acceptable and effective PTSD treatments could reduce the economic costs of PTSD and the burden on women veterans and their families. The findings of this RCT demonstrate that TCTSY is an effective and acceptable treatment to be added to current EBTs. Policy and practice changes to include TCTSY could be a cost-effective means to expand PTSD treatment options; provide a treatment that could improve associated symptoms, such as depression and anxiety; potentially mitigate PTSD-related physical symptoms and comorbidities; address veterans’ preferences for CIH therapies; and increase access to acceptable, patient-driven, and effective PTSD treatment.